The chemokine (C-C motif) ligand 2 (CCL2)/chemokine (C-C motif) receptor 2 (CCR2) signaling axis contributes to tumor progression through CCR2-mediated MDSC recruitment and/or accumulation [19–21]. This evidence concerns the gene CCL2 and neoplasm.